Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes
1
Department of Pharmaceutical Technology and Biopharmaceutics, Philipps-Universität, Marburg, Germany
2
Department of neuro surgery, Universitätsklinikum Gießen und Marburg GmbH, Philipps-Universität, Marburg, Germany
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 675; https://doi.org/10.3797/scipharm.cespt.8.PNM05
Submission received: 12 July 2010
/
Accepted: 12 July 2010
/
Published: 12 July 2010
Abstract
Blood vessel diseases like antherosclerosis lead to formation of blood clots with severe consequences like acute ischemic stroke or myocardial infarction [1]. [...]
Share and Cite
MDPI and ACS Style
MARXER, E.E.J.; BRÜßLER, J.; BECKER, A.; NIMSKY, C.; BAKOWSKY, U. Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes. Sci. Pharm. 2010, 78, 675. https://doi.org/10.3797/scipharm.cespt.8.PNM05
AMA Style
MARXER EEJ, BRÜßLER J, BECKER A, NIMSKY C, BAKOWSKY U. Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes. Scientia Pharmaceutica. 2010; 78(3):675. https://doi.org/10.3797/scipharm.cespt.8.PNM05
Chicago/Turabian StyleMARXER, E. E. J., J. BRÜßLER, A. BECKER, C. NIMSKY, and U. BAKOWSKY. 2010. "Fibrin Targeting with Ultrasound Active Antibody-Conjugated Liposomes" Scientia Pharmaceutica 78, no. 3: 675. https://doi.org/10.3797/scipharm.cespt.8.PNM05
